Отправить статью по E-mail mRNA-based therapeutics–Advances and perspectives
- Авторы: Sergeeva O.V.1,2, Koteliansky V.E.1,2, Zatsepin T.S.1,2,3
-
Учреждения:
- Department of Chemistry
- Skolkovo Innovation Center
- The Federal Service on Customers’ Rights Protection and Human Well-being Surveillance
- Выпуск: Том 81, № 7 (2016)
- Страницы: 709-722
- Раздел: Review
- URL: https://journals.rcsi.science/0006-2979/article/view/150939
- DOI: https://doi.org/10.1134/S0006297916070075
- ID: 150939
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo. Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.
Ключевые слова
Об авторах
O. Sergeeva
Department of Chemistry; Skolkovo Innovation Center
Автор, ответственный за переписку.
Email: olga.sergeeva.v@gmail.com
Россия, Moscow, 119991; 3 Nobel str., Moscow, 143026
V. Koteliansky
Department of Chemistry; Skolkovo Innovation Center
Email: olga.sergeeva.v@gmail.com
Россия, Moscow, 119991; 3 Nobel str., Moscow, 143026
T. Zatsepin
Department of Chemistry; Skolkovo Innovation Center; The Federal Service on Customers’ Rights Protection and Human Well-being Surveillance
Email: olga.sergeeva.v@gmail.com
Россия, Moscow, 119991; 3 Nobel str., Moscow, 143026; Moscow, 111123
Дополнительные файлы
